Europe — EMA

Paclitaxel Onkovis

Paclitaxel, the active ingredient in Paclitaxel Onkovis, is a chemotherapy agent presented as a sterile injectable solution for intravenous use.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Onkovis, is a chemotherapy agent presented as a sterile injectable solution for intravenous use. It treats various malignant neoplasms and is administered under the supervision of oncology specialists.

GNH USA supplies Paclitaxel Onkovis as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

What is Paclitaxel used for?

Paclitaxel Onkovis is employed across several oncologic pathways: - Breast cancer: Improves the overall response to chemotherapy in patients with early stage disease. - Ovarian cancer: Used as a first‑line treatment in combination with carb c - Non‑small cell lung C a t t a t - t ",

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →